We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Fungus-Associated Bacteriome Associated with C. difficile Infection

By LabMedica International staff writers
Posted on 11 Sep 2019
Clostridioides difficile infection (CDI), the most common etiology of nosocomial infectious diarrhea, is caused by an intestinal dysbiosis that is virtually always attributable to antibiotics. More...
This causes one of the most common hospital-acquired infections in the USA.

There is a growing body of data showing that distinct bacterial and fungal community structures distinguish the dysbiotic state of CDI from antibiotic-associated diarrhea due to other causes. The data suggests that transkingdom interactions between fungal and bacterial species play an important role in nosocomial infections.

A team of scientists collaborating with the University of Arizona (Tucson, AZ, USA) collected diarrheal stools from 49 inpatients (18 of whom tested positive for CDI) under stringent inclusion criteria. C. difficile testing was performed using a commercially available nucleic acid amplification test designed to detect a highly conserved sequence within the tcdA gene. C. difficile positive and negative stool samples were preserved.

Fecal DNA extracts were subject to 16S rRNA gene and ITS2 Illumina tag polymerase chain reaction (PCR) (Illumina, San Diego, CA, USA; www.illumina.com), pooled in equimolar ratios, gel purified, and sequenced on the Illumina MiSeq (16S rRNA libraries) and NextSeq (ITS libraries) platforms. Bacterial (16S rRNA gene) and fungal (ITS) sequences were quality filtered, clustered into operational taxonomic units (OTUs), and normalized using both the USEARCH and QIIME pipelines. The team utilized a tiered sequencing approach to identify enriched bacterial and fungal taxa, using 16S and internal transcribed spacer (ITS) rRNA gene amplicon sequencing, with matched metagenomics and metatranscriptomics performed on a subset of the population.

The scientists reported that distinct bacterial and fungal compositions distinguished CDI-positive and -negative patients, with the greatest differentiation between the cohorts observed based on bacterial metatranscriptomics. Bipartite network analyses demonstrated that Aspergillus and Penicillium taxa shared a strong positive relationship in CDI patients and together formed negative co-occurring relationships with several bacterial taxa, including the Oscillospira, Comamonadaceae, Microbacteriaceae, and Cytophagaceae. The investigators identified new pathways associated with C. difficile infections. Those pathways pointed to still other bacterial species, including Escherichia coli that may contribute to the dysbiosis, or imbalance among bacterial species in the gut, associated with C. difficile.

David B. Stewart, MD, a surgeon and first author of the study, said, “The development of C. difficile infection is apparently influenced both by bacterial pathogens and fungi particular to this disease. Until now, fungi have been understudied and under-appreciated in the gut microbiome.” The study was published on August 28, 2019, in the journal mSphere.

Related Links:
University of Arizona


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Aspiration System
VACUSAFE
LAIR2 Antibody Pair Set
LAIR2 Antibody Pair [Biotin]
New
Gastrointestinal Panel
Xpert® GI Panel
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The screening algorithm incorporates two plasma biomarkers: amyloid-beta ratio and p-tau217, which together help indicate brain amyloid burden (Image Credit: Shutterstock)

Algorithm Uses Blood Biomarkers to Improve Alzheimer’s Trial Screening

Alzheimer’s disease is a progressive neurodegenerative disorder that causes memory loss and functional decline. Screening cognitively healthy adults for prevention trials is slow and costly because many... Read more

Technology

view channel
Image: The 5811 R retains the performance and versatility of its predecessor while adding a new design, a refreshed user interface, and updated sustainable cooling technology. (Photo courtesy of Eppendorf)

New Multipurpose Centrifuge Combines High Capacity with Sustainable Cooling

Laboratories often need centrifugation that accommodates multiple vessel formats while maintaining controlled temperatures to protect sensitive samples. Intuitive controls and repeatable operation can... Read more

Industry

view channel
Image: The combined offering is designed to streamline workflows and support multicolor applications used in leukemia, lymphoma, and measurable residual disease assessment in specialized clinical settings

Sysmex and Cytek Collaboration Expands Access to Advanced Clinical Flow Cytometry

Sysmex Europe SE (Hamburg, Germany) and Cytek Biosciences (Fremont, CA, USA) are partnering across more than a dozen European countries to expand access to advanced clinical flow cytometry.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.